Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Liabilities from Discontinued Operations (2022 - 2024)

Mimedx's Liabilities from Discontinued Operations history spans 3 years, with the latest figure at 217000.0 for Q2 2024.

  • On a quarterly basis, Liabilities from Discontinued Operations changed N/A to 217000.0 in Q2 2024 year-over-year; TTM through Jun 2024 was 217000.0, a N/A change, with the full-year FY2023 number at 1352000.0, down 8.59% from a year prior.
  • Liabilities from Discontinued Operations hit 217000.0 in Q2 2024 for Mimedx, down from 344000.0 in the prior quarter.
  • Over the last five years, Liabilities from Discontinued Operations for MDXG hit a ceiling of 1479000.0 in Q4 2022 and a floor of 217000.0 in Q2 2024.
  • Historically, Liabilities from Discontinued Operations has averaged 848000.0 across 3 years, with a median of 848000.0 in 2023.
  • The widest YoY moves for Liabilities from Discontinued Operations: up 8.59% in 2023, down 8.59% in 2023.
  • Tracing MDXG's Liabilities from Discontinued Operations over 3 years: stood at 1479000.0 in 2022, then decreased by 8.59% to 1352000.0 in 2023, then crashed by 83.95% to 217000.0 in 2024.
  • Business Quant data shows Liabilities from Discontinued Operations for MDXG at 217000.0 in Q2 2024, 344000.0 in Q1 2024, and 1352000.0 in Q4 2023.